Metraipolis › archive › dc_2166e243da70
Biomimetic and personalized nanovaccines in cancer immunotherapy: Design innovations, translational challenges, and future directions — Europe PMC PMID:41638631
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41638631
- DOI
- 10.1016/j.jare.2026.01.070
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T04:30:01.847Z
- SHA-256 of the archived text
63d32aa5655f193dc4d594b5df4006410e205953054f95627d315c677b71aa0b- Stable URL of this page
https://metraipolis.com/documento/dc_2166e243da70
How to cite
Biomimetic and personalized nanovaccines in cancer immunotherapy: Design innovations, translational challenges, and future directions — Europe PMC PMID:41638631 — Europe PMC (en), https://europepmc.org/article/MED/41638631 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2166e243da70 (Metraipolis archive dc_2166e243da70, sha256 63d32aa5655f193dc4d594b5df4006410e205953054f95627d315c677b71aa0b)
BibTeX
@misc{dc2166e243da70,
title = {Biomimetic and personalized nanovaccines in cancer immunotherapy: Design innovations, translational challenges, and future directions — Europe PMC PMID:41638631},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41638631},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2166e243da70; sha256 63d32aa5655f193dc4d594b5df4006410e205953054f95627d315c677b71aa0b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41638631. Agents can read the archived copy with the MCP tool read_document.